 | • レポートコード：MMG23DC14248 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英語、PDF、102ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品 |
| Single User（1名様閲覧用） | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Multi User（20名様閲覧用） | ￥633,750 (USD4,225) | ▷ お問い合わせ |
| Enterprise User（閲覧人数制限なし） | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の植物薬市場規模と予測を収録しています。・世界の植物薬市場：売上、2018年-2023年、2024年-2029年 ・世界の植物薬市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の植物薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「医療用医薬品」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 植物薬のグローバル主要企業は、Buchang Pharmaceuticals、 China TCM、 Tsumura、 Schwabe、 Tong Ren Tang、 Jumpcan Pharmaceutical、 Guangzhou Baiyunshan Pharmaceutical、 Yunnan Baiyao、 Tasly Holding Group、 Bionorica Se、 Huarun 999、 Taiji、 Weleda、 Kwangdong、 GW Pharmaceuticalsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、植物薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の植物薬市場：タイプ別、2018年-2023年、2024年-2029年 世界の植物薬市場：タイプ別市場シェア、2022年 ・医療用医薬品、OTC 世界の植物薬市場：用途別、2018年-2023年、2024年-2029年 世界の植物薬市場：用途別市場シェア、2022年 ・心臓血管、腫瘍、呼吸器系、その他 世界の植物薬市場：地域・国別、2018年-2023年、2024年-2029年 世界の植物薬市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における植物薬のグローバル売上、2018年-2023年 ・主要企業における植物薬のグローバル売上シェア、2022年 ・主要企業における植物薬のグローバル販売量、2018年-2023年 ・主要企業における植物薬のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Buchang Pharmaceuticals、 China TCM、 Tsumura、 Schwabe、 Tong Ren Tang、 Jumpcan Pharmaceutical、 Guangzhou Baiyunshan Pharmaceutical、 Yunnan Baiyao、 Tasly Holding Group、 Bionorica Se、 Huarun 999、 Taiji、 Weleda、 Kwangdong、 GW Pharmaceuticals ************************************************************* ・調査・分析レポートの概要 植物薬市場の定義 市場セグメント 世界の植物薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の植物薬市場規模 世界の植物薬市場規模：2022年 VS 2029年 世界の植物薬市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの植物薬の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の植物薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：医療用医薬品、OTC 植物薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：心臓血管、腫瘍、呼吸器系、その他 植物薬の用途別グローバル売上・予測 ・地域別市場分析 地域別植物薬市場規模 2022年と2029年 地域別植物薬売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Buchang Pharmaceuticals、 China TCM、 Tsumura、 Schwabe、 Tong Ren Tang、 Jumpcan Pharmaceutical、 Guangzhou Baiyunshan Pharmaceutical、 Yunnan Baiyao、 Tasly Holding Group、 Bionorica Se、 Huarun 999、 Taiji、 Weleda、 Kwangdong、 GW Pharmaceuticals ... |
This research report provides a comprehensive analysis of the Botanical Drug market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Botanical Drug market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Botanical Drug, challenges faced by the industry, and potential opportunities for market players.
The global Botanical Drug market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Botanical Drug market presents opportunities for various stakeholders, including Cardiovascular, Tumor. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Botanical Drug market. Additionally, the growing consumer demand present avenues for market expansion.
The global Botanical Drug market was valued at US$ 34430 million in 2022 and is projected to reach US$ 48380 million by 2029, at a CAGR of 5.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global 5 largest manufacturers of Botanical Drug are Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe and Tong Ren Tang, which make up over 20%. Among them, Buchang Pharmaceuticals is the leader with about 7% market share.
China is the largest market, with a share over 60%, followed by Europe and Japan, with the share about 5% and 4%. In terms of product type, OTC occupy the largest share of the total market, over 60%. And in terms of application, the largest application is Cardiovascular, followed by Respiratory System and Tumor.
Key Features:
The research report on the Botanical Drug market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Botanical Drug market.
Market Overview: The report provides a comprehensive overview of the Botanical Drug market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Prescription Drug, OTC）, region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Botanical Drug market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Botanical Drug market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Botanical Drug market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Botanical Drug market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Botanical Drug market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Botanical Drug market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Botanical Drug, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Botanical Drug market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Botanical Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Prescription Drug
OTC
Market segment by Application
Cardiovascular
Tumor
Respiratory System
Others
Global Botanical Drug Market Segment Percentages, By Region and Country, 2022 (%）
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Buchang Pharmaceuticals
China TCM
Tsumura
Schwabe
Tong Ren Tang
Jumpcan Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Yunnan Baiyao
Tasly Holding Group
Bionorica Se
Huarun 999
Taiji
Weleda
Kwangdong
GW Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Botanical Drug, market overview.
Chapter 2: Global Botanical Drug market size in revenue.
Chapter 3: Detailed analysis of Botanical Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Botanical Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Botanical Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Botanical Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Botanical Drug Overall Market Size
2.1 Global Botanical Drug Market Size: 2022 VS 2029
2.2 Global Botanical Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Botanical Drug Players in Global Market
3.2 Top Global Botanical Drug Companies Ranked by Revenue
3.3 Global Botanical Drug Revenue by Companies
3.4 Top 3 and Top 5 Botanical Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Botanical Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Botanical Drug Players in Global Market
3.6.1 List of Global Tier 1 Botanical Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Botanical Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Botanical Drug Market Size Markets, 2022 & 2029
4.1.2 Prescription Drug
4.1.3 OTC
4.2 By Type – Global Botanical Drug Revenue & Forecasts
4.2.1 By Type – Global Botanical Drug Revenue, 2018-2023
4.2.2 By Type – Global Botanical Drug Revenue, 2024-2029
4.2.3 By Type – Global Botanical Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Botanical Drug Market Size, 2022 & 2029
5.1.2 Cardiovascular
5.1.3 Tumor
5.1.4 Respiratory System
5.1.5 Others
5.2 By Application – Global Botanical Drug Revenue & Forecasts
5.2.1 By Application – Global Botanical Drug Revenue, 2018-2023
5.2.2 By Application – Global Botanical Drug Revenue, 2024-2029
5.2.3 By Application – Global Botanical Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Botanical Drug Market Size, 2022 & 2029
6.2 By Region – Global Botanical Drug Revenue & Forecasts
6.2.1 By Region – Global Botanical Drug Revenue, 2018-2023
6.2.2 By Region – Global Botanical Drug Revenue, 2024-2029
6.2.3 By Region – Global Botanical Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Botanical Drug Revenue, 2018-2029
6.3.2 US Botanical Drug Market Size, 2018-2029
6.3.3 Canada Botanical Drug Market Size, 2018-2029
6.3.4 Mexico Botanical Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Botanical Drug Revenue, 2018-2029
6.4.2 Germany Botanical Drug Market Size, 2018-2029
6.4.3 France Botanical Drug Market Size, 2018-2029
6.4.4 U.K. Botanical Drug Market Size, 2018-2029
6.4.5 Italy Botanical Drug Market Size, 2018-2029
6.4.6 Russia Botanical Drug Market Size, 2018-2029
6.4.7 Nordic Countries Botanical Drug Market Size, 2018-2029
6.4.8 Benelux Botanical Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Botanical Drug Revenue, 2018-2029
6.5.2 China Botanical Drug Market Size, 2018-2029
6.5.3 Japan Botanical Drug Market Size, 2018-2029
6.5.4 South Korea Botanical Drug Market Size, 2018-2029
6.5.5 Southeast Asia Botanical Drug Market Size, 2018-2029
6.5.6 India Botanical Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Botanical Drug Revenue, 2018-2029
6.6.2 Brazil Botanical Drug Market Size, 2018-2029
6.6.3 Argentina Botanical Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Botanical Drug Revenue, 2018-2029
6.7.2 Turkey Botanical Drug Market Size, 2018-2029
6.7.3 Israel Botanical Drug Market Size, 2018-2029
6.7.4 Saudi Arabia Botanical Drug Market Size, 2018-2029
6.7.5 UAE Botanical Drug Market Size, 2018-2029
7 Botanical Drug Companies Profiles
7.1 Buchang Pharmaceuticals
7.1.1 Buchang Pharmaceuticals Company Summary
7.1.2 Buchang Pharmaceuticals Business Overview
7.1.3 Buchang Pharmaceuticals Botanical Drug Major Product Offerings
7.1.4 Buchang Pharmaceuticals Botanical Drug Revenue in Global Market (2018-2023）
7.1.5 Buchang Pharmaceuticals Key News & Latest Developments
7.2 China TCM
7.2.1 China TCM Company Summary
7.2.2 China TCM Business Overview
7.2.3 China TCM Botanical Drug Major Product Offerings
7.2.4 China TCM Botanical Drug Revenue in Global Market (2018-2023）
7.2.5 China TCM Key News & Latest Developments
7.3 Tsumura
7.3.1 Tsumura Company Summary
7.3.2 Tsumura Business Overview
7.3.3 Tsumura Botanical Drug Major Product Offerings
7.3.4 Tsumura Botanical Drug Revenue in Global Market (2018-2023）
7.3.5 Tsumura Key News & Latest Developments
7.4 Schwabe
7.4.1 Schwabe Company Summary
7.4.2 Schwabe Business Overview
7.4.3 Schwabe Botanical Drug Major Product Offerings
7.4.4 Schwabe Botanical Drug Revenue in Global Market (2018-2023）
7.4.5 Schwabe Key News & Latest Developments
7.5 Tong Ren Tang
7.5.1 Tong Ren Tang Company Summary
7.5.2 Tong Ren Tang Business Overview
7.5.3 Tong Ren Tang Botanical Drug Major Product Offerings
7.5.4 Tong Ren Tang Botanical Drug Revenue in Global Market (2018-2023）
7.5.5 Tong Ren Tang Key News & Latest Developments
7.6 Jumpcan Pharmaceutical
7.6.1 Jumpcan Pharmaceutical Company Summary
7.6.2 Jumpcan Pharmaceutical Business Overview
7.6.3 Jumpcan Pharmaceutical Botanical Drug Major Product Offerings
7.6.4 Jumpcan Pharmaceutical Botanical Drug Revenue in Global Market (2018-2023）
7.6.5 Jumpcan Pharmaceutical Key News & Latest Developments
7.7 Guangzhou Baiyunshan Pharmaceutical
7.7.1 Guangzhou Baiyunshan Pharmaceutical Company Summary
7.7.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
7.7.3 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Major Product Offerings
7.7.4 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue in Global Market (2018-2023）
7.7.5 Guangzhou Baiyunshan Pharmaceutical Key News & Latest Developments
7.8 Yunnan Baiyao
7.8.1 Yunnan Baiyao Company Summary
7.8.2 Yunnan Baiyao Business Overview
7.8.3 Yunnan Baiyao Botanical Drug Major Product Offerings
7.8.4 Yunnan Baiyao Botanical Drug Revenue in Global Market (2018-2023）
7.8.5 Yunnan Baiyao Key News & Latest Developments
7.9 Tasly Holding Group
7.9.1 Tasly Holding Group Company Summary
7.9.2 Tasly Holding Group Business Overview
7.9.3 Tasly Holding Group Botanical Drug Major Product Offerings
7.9.4 Tasly Holding Group Botanical Drug Revenue in Global Market (2018-2023）
7.9.5 Tasly Holding Group Key News & Latest Developments
7.10 Bionorica Se
7.10.1 Bionorica Se Company Summary
7.10.2 Bionorica Se Business Overview
7.10.3 Bionorica Se Botanical Drug Major Product Offerings
7.10.4 Bionorica Se Botanical Drug Revenue in Global Market (2018-2023）
7.10.5 Bionorica Se Key News & Latest Developments
7.11 Huarun 999
7.11.1 Huarun 999 Company Summary
7.11.2 Huarun 999 Business Overview
7.11.3 Huarun 999 Botanical Drug Major Product Offerings
7.11.4 Huarun 999 Botanical Drug Revenue in Global Market (2018-2023）
7.11.5 Huarun 999 Key News & Latest Developments
7.12 Taiji
7.12.1 Taiji Company Summary
7.12.2 Taiji Business Overview
7.12.3 Taiji Botanical Drug Major Product Offerings
7.12.4 Taiji Botanical Drug Revenue in Global Market (2018-2023）
7.12.5 Taiji Key News & Latest Developments
7.13 Weleda
7.13.1 Weleda Company Summary
7.13.2 Weleda Business Overview
7.13.3 Weleda Botanical Drug Major Product Offerings
7.13.4 Weleda Botanical Drug Revenue in Global Market (2018-2023）
7.13.5 Weleda Key News & Latest Developments
7.14 Kwangdong
7.14.1 Kwangdong Company Summary
7.14.2 Kwangdong Business Overview
7.14.3 Kwangdong Botanical Drug Major Product Offerings
7.14.4 Kwangdong Botanical Drug Revenue in Global Market (2018-2023）
7.14.5 Kwangdong Key News & Latest Developments
7.15 GW Pharmaceuticals
7.15.1 GW Pharmaceuticals Company Summary
7.15.2 GW Pharmaceuticals Business Overview
7.15.3 GW Pharmaceuticals Botanical Drug Major Product Offerings
7.15.4 GW Pharmaceuticals Botanical Drug Revenue in Global Market (2018-2023）
7.15.5 GW Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Table 1. Botanical Drug Market Opportunities & Trends in Global Market
Table 2. Botanical Drug Market Drivers in Global Market
Table 3. Botanical Drug Market Restraints in Global Market
Table 4. Key Players of Botanical Drug in Global Market
Table 5. Top Botanical Drug Players in Global Market, Ranking by Revenue (2022）
Table 6. Global Botanical Drug Revenue by Companies, (US$, Mn）, 2018-2023
Table 7. Global Botanical Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Botanical Drug Product Type
Table 9. List of Global Tier 1 Botanical Drug Companies, Revenue (US$, Mn） in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Botanical Drug Companies, Revenue (US$, Mn） in 2022 and Market Share
Table 11. By Type – Global Botanical Drug Revenue, (US$, Mn）, 2022 & 2029
Table 12. By Type - Botanical Drug Revenue in Global (US$, Mn）, 2018-2023
Table 13. By Type - Botanical Drug Revenue in Global (US$, Mn）, 2024-2029
Table 14. By Application – Global Botanical Drug Revenue, (US$, Mn）, 2022 & 2029
Table 15. By Application - Botanical Drug Revenue in Global (US$, Mn）, 2018-2023
Table 16. By Application - Botanical Drug Revenue in Global (US$, Mn）, 2024-2029
Table 17. By Region – Global Botanical Drug Revenue, (US$, Mn）, 2022 & 2029
Table 18. By Region - Global Botanical Drug Revenue (US$, Mn）, 2018-2023
Table 19. By Region - Global Botanical Drug Revenue (US$, Mn）, 2024-2029
Table 20. By Country - North America Botanical Drug Revenue, (US$, Mn）, 2018-2023
Table 21. By Country - North America Botanical Drug Revenue, (US$, Mn）, 2024-2029
Table 22. By Country - Europe Botanical Drug Revenue, (US$, Mn）, 2018-2023
Table 23. By Country - Europe Botanical Drug Revenue, (US$, Mn）, 2024-2029
Table 24. By Region - Asia Botanical Drug Revenue, (US$, Mn）, 2018-2023
Table 25. By Region - Asia Botanical Drug Revenue, (US$, Mn）, 2024-2029
Table 26. By Country - South America Botanical Drug Revenue, (US$, Mn）, 2018-2023
Table 27. By Country - South America Botanical Drug Revenue, (US$, Mn）, 2024-2029
Table 28. By Country - Middle East & Africa Botanical Drug Revenue, (US$, Mn）, 2018-2023
Table 29. By Country - Middle East & Africa Botanical Drug Revenue, (US$, Mn）, 2024-2029
Table 30. Buchang Pharmaceuticals Company Summary
Table 31. Buchang Pharmaceuticals Botanical Drug Product Offerings
Table 32. Buchang Pharmaceuticals Botanical Drug Revenue (US$, Mn） & (2018-2023）
Table 33. Buchang Pharmaceuticals Key News & Latest Developments
Table 34. China TCM Company Summary
Table 35. China TCM Botanical Drug Product Offerings
Table 36. China TCM Botanical Drug Revenue (US$, Mn） & (2018-2023）
Table 37. China TCM Key News & Latest Developments
Table 38. Tsumura Company Summary
Table 39. Tsumura Botanical Drug Product Offerings
Table 40. Tsumura Botanical Drug Revenue (US$, Mn） & (2018-2023）
Table 41. Tsumura Key News & Latest Developments
Table 42. Schwabe Company Summary
Table 43. Schwabe Botanical Drug Product Offerings
Table 44. Schwabe Botanical Drug Revenue (US$, Mn） & (2018-2023）
Table 45. Schwabe Key News & Latest Developments
Table 46. Tong Ren Tang Company Summary
Table 47. Tong Ren Tang Botanical Drug Product Offerings
Table 48. Tong Ren Tang Botanical Drug Revenue (US$, Mn） & (2018-2023）
Table 49. Tong Ren Tang Key News & Latest Developments
Table 50. Jumpcan Pharmaceutical Company Summary
Table 51. Jumpcan Pharmaceutical Botanical Drug Product Offerings
Table 52. Jumpcan Pharmaceutical Botanical Drug Revenue (US$, Mn） & (2018-2023）
Table 53. Jumpcan Pharmaceutical Key News & Latest Developments
Table 54. Guangzhou Baiyunshan Pharmaceutical Company Summary
Table 55. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product Offerings
Table 56. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue (US$, Mn） & (2018-2023）
Table 57. Guangzhou Baiyunshan Pharmaceutical Key News & Latest Developments
Table 58. Yunnan Baiyao Company Summary
Table 59. Yunnan Baiyao Botanical Drug Product Offerings
Table 60. Yunnan Baiyao Botanical Drug Revenue (US$, Mn） & (2018-2023）
Table 61. Yunnan Baiyao Key News & Latest Developments
Table 62. Tasly Holding Group Company Summary
Table 63. Tasly Holding Group Botanical Drug Product Offerings
Table 64. Tasly Holding Group Botanical Drug Revenue (US$, Mn） & (2018-2023）
Table 65. Tasly Holding Group Key News & Latest Developments
Table 66. Bionorica Se Company Summary
Table 67. Bionorica Se Botanical Drug Product Offerings
Table 68. Bionorica Se Botanical Drug Revenue (US$, Mn） & (2018-2023）
Table 69. Bionorica Se Key News & Latest Developments
Table 70. Huarun 999 Company Summary
Table 71. Huarun 999 Botanical Drug Product Offerings
Table 72. Huarun 999 Botanical Drug Revenue (US$, Mn） & (2018-2023）
Table 73. Huarun 999 Key News & Latest Developments
Table 74. Taiji Company Summary
Table 75. Taiji Botanical Drug Product Offerings
Table 76. Taiji Botanical Drug Revenue (US$, Mn） & (2018-2023）
Table 77. Taiji Key News & Latest Developments
Table 78. Weleda Company Summary
Table 79. Weleda Botanical Drug Product Offerings
Table 80. Weleda Botanical Drug Revenue (US$, Mn） & (2018-2023）
Table 81. Weleda Key News & Latest Developments
Table 82. Kwangdong Company Summary
Table 83. Kwangdong Botanical Drug Product Offerings
Table 84. Kwangdong Botanical Drug Revenue (US$, Mn） & (2018-2023）
Table 85. Kwangdong Key News & Latest Developments
Table 86. GW Pharmaceuticals Company Summary
Table 87. GW Pharmaceuticals Botanical Drug Product Offerings
Table 88. GW Pharmaceuticals Botanical Drug Revenue (US$, Mn） & (2018-2023）
Table 89. GW Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Botanical Drug Segment by Type in 2022
Figure 2. Botanical Drug Segment by Application in 2022
Figure 3. Global Botanical Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Botanical Drug Market Size: 2022 VS 2029 (US$, Mn）
Figure 6. Global Botanical Drug Revenue, 2018-2029 (US$, Mn）
Figure 7. The Top 3 and 5 Players Market Share by Botanical Drug Revenue in 2022
Figure 8. By Type - Global Botanical Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global Botanical Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global Botanical Drug Revenue, (US$, Mn）, 2022 & 2029
Figure 11. By Type - Global Botanical Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global Botanical Drug Revenue, (US$, Mn）, 2022 & 2029
Figure 13. By Application - Global Botanical Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global Botanical Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America Botanical Drug Revenue Market Share, 2018-2029
Figure 16. US Botanical Drug Revenue, (US$, Mn）, 2018-2029
Figure 17. Canada Botanical Drug Revenue, (US$, Mn）, 2018-2029
Figure 18. Mexico Botanical Drug Revenue, (US$, Mn）, 2018-2029
Figure 19. By Country - Europe Botanical Drug Revenue Market Share, 2018-2029
Figure 20. Germany Botanical Drug Revenue, (US$, Mn）, 2018-2029
Figure 21. France Botanical Drug Revenue, (US$, Mn）, 2018-2029
Figure 22. U.K. Botanical Drug Revenue, (US$, Mn）, 2018-2029
Figure 23. Italy Botanical Drug Revenue, (US$, Mn）, 2018-2029
Figure 24. Russia Botanical Drug Revenue, (US$, Mn）, 2018-2029
Figure 25. Nordic Countries Botanical Drug Revenue, (US$, Mn）, 2018-2029
Figure 26. Benelux Botanical Drug Revenue, (US$, Mn）, 2018-2029
Figure 27. By Region - Asia Botanical Drug Revenue Market Share, 2018-2029
Figure 28. China Botanical Drug Revenue, (US$, Mn）, 2018-2029
Figure 29. Japan Botanical Drug Revenue, (US$, Mn）, 2018-2029
Figure 30. South Korea Botanical Drug Revenue, (US$, Mn）, 2018-2029
Figure 31. Southeast Asia Botanical Drug Revenue, (US$, Mn）, 2018-2029
Figure 32. India Botanical Drug Revenue, (US$, Mn）, 2018-2029
Figure 33. By Country - South America Botanical Drug Revenue Market Share, 2018-2029
Figure 34. Brazil Botanical Drug Revenue, (US$, Mn）, 2018-2029
Figure 35. Argentina Botanical Drug Revenue, (US$, Mn）, 2018-2029
Figure 36. By Country - Middle East & Africa Botanical Drug Revenue Market Share, 2018-2029
Figure 37. Turkey Botanical Drug Revenue, (US$, Mn）, 2018-2029
Figure 38. Israel Botanical Drug Revenue, (US$, Mn）, 2018-2029
Figure 39. Saudi Arabia Botanical Drug Revenue, (US$, Mn）, 2018-2029
Figure 40. UAE Botanical Drug Revenue, (US$, Mn）, 2018-2029
Figure 41. Buchang Pharmaceuticals Botanical Drug Revenue Year Over Year Growth (US$, Mn） & (2018-2023）
Figure 42. China TCM Botanical Drug Revenue Year Over Year Growth (US$, Mn） & (2018-2023）
Figure 43. Tsumura Botanical Drug Revenue Year Over Year Growth (US$, Mn） & (2018-2023）
Figure 44. Schwabe Botanical Drug Revenue Year Over Year Growth (US$, Mn） & (2018-2023）
Figure 45. Tong Ren Tang Botanical Drug Revenue Year Over Year Growth (US$, Mn） & (2018-2023）
Figure 46. Jumpcan Pharmaceutical Botanical Drug Revenue Year Over Year Growth (US$, Mn） & (2018-2023）
Figure 47. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue Year Over Year Growth (US$, Mn） & (2018-2023）
Figure 48. Yunnan Baiyao Botanical Drug Revenue Year Over Year Growth (US$, Mn） & (2018-2023）
Figure 49. Tasly Holding Group Botanical Drug Revenue Year Over Year Growth (US$, Mn） & (2018-2023）
Figure 50. Bionorica Se Botanical Drug Revenue Year Over Year Growth (US$, Mn） & (2018-2023）
Figure 51. Huarun 999 Botanical Drug Revenue Year Over Year Growth (US$, Mn） & (2018-2023）
Figure 52. Taiji Botanical Drug Revenue Year Over Year Growth (US$, Mn） & (2018-2023）
Figure 53. Weleda Botanical Drug Revenue Year Over Year Growth (US$, Mn） & (2018-2023）
Figure 54. Kwangdong Botanical Drug Revenue Year Over Year Growth (US$, Mn） & (2018-2023）
Figure 55. GW Pharmaceuticals Botanical Drug Revenue Year Over Year Growth (US$, Mn） & (2018-2023）